Does the media favor HCAT or CGNT?

In the previous week, Health Catalyst had 7 more articles in the media than Cognyte Software. MarketBeat recorded 8 mentions for Health Catalyst and 1 mentions for Cognyte Software. Cognyte Software's average media sentiment score of 1.87 beat Health Catalyst's score of 0.49 indicating that Cognyte Software is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 1 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cognyte Software 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has higher earnings and valuation, HCAT or MOMO?

Hello Group has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Hello Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Health Catalyst $311.14M 0.48 -$177.97M -$3.72 N/A Hello Group $10.23B 0.06 $114.97M $0.64 9.27

Does the media favor HCAT or MOMO?

In the previous week, Health Catalyst had 6 more articles in the media than Hello Group. MarketBeat recorded 8 mentions for Health Catalyst and 2 mentions for Hello Group. Health Catalyst's average media sentiment score of 0.49 beat Hello Group's score of 0.30 indicating that Health Catalyst is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 1 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hello Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PUBM or HCAT?

In the previous week, Health Catalyst had 2 more articles in the media than PubMatic. MarketBeat recorded 8 mentions for Health Catalyst and 6 mentions for PubMatic. PubMatic's average media sentiment score of 0.54 beat Health Catalyst's score of 0.49 indicating that PubMatic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PubMatic 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Health Catalyst 1 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor HCAT or SMWB?

In the previous week, Health Catalyst had 7 more articles in the media than Similarweb. MarketBeat recorded 8 mentions for Health Catalyst and 1 mentions for Similarweb. Similarweb's average media sentiment score of 0.67 beat Health Catalyst's score of 0.49 indicating that Similarweb is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 1 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Similarweb 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HCAT or WEAV?

In the previous week, Health Catalyst had 5 more articles in the media than Weave Communications. MarketBeat recorded 8 mentions for Health Catalyst and 3 mentions for Weave Communications. Health Catalyst's average media sentiment score of 0.49 beat Weave Communications' score of 0.46 indicating that Health Catalyst is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 1 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Weave Communications 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Health Catalyst (HCAT) Competitors

$2.04 -0.06 (-2.86%)

Closing price 07/22/2026 04:00 PM Eastern

Extended Trading

$2.06 +0.02 (+0.78%)

As of 07/22/2026 07:36 PM Eastern

Compare

HCAT vs. CGNT, MOMO, PUBM, SMWB, and WEAV

Should you buy Health Catalyst stock or one of its competitors? MarketBeat compares Health Catalyst with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Health Catalyst include Cognyte Software (CGNT), Hello Group (MOMO), PubMatic (PUBM), Similarweb (SMWB), and Weave Communications (WEAV). These companies are all part of the "computer software" industry.

How does Health Catalyst compare to Cognyte Software?

Health Catalyst (NASDAQ:HCAT) and Cognyte Software (NASDAQ:CGNT) are both small-cap computer software companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

Cognyte Software has higher revenue and earnings than Health Catalyst. Cognyte Software is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.48	-$177.97M	-$3.72	N/A
Cognyte Software	$409.99M	1.48	-$640K	-$0.04	N/A

Health Catalyst presently has a consensus price target of $2.93, indicating a potential upside of 43.72%. Cognyte Software has a consensus price target of $13.50, indicating a potential upside of 62.26%. Given Cognyte Software's higher probable upside, analysts plainly believe Cognyte Software is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23
Cognyte Software	2 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cognyte Software has a net margin of -0.66% compared to Health Catalyst's net margin of -87.69%. Cognyte Software's return on equity of -0.45% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-87.69%	-3.52%	-1.77%
Cognyte Software	-0.66%	-0.45%	-0.20%

Health Catalyst has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market. Comparatively, Cognyte Software has a beta of 1.68, indicating that its share price is 68% more volatile than the broader market.

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 72.9% of Cognyte Software shares are held by institutional investors. 19.4% of Health Catalyst shares are held by insiders. Comparatively, 62.7% of Cognyte Software shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Health Catalyst had 7 more articles in the media than Cognyte Software. MarketBeat recorded 8 mentions for Health Catalyst and 1 mentions for Cognyte Software. Cognyte Software's average media sentiment score of 1.87 beat Health Catalyst's score of 0.49 indicating that Cognyte Software is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	1 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cognyte Software	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Cognyte Software beats Health Catalyst on 11 of the 16 factors compared between the two stocks.

How does Health Catalyst compare to Hello Group?

Health Catalyst (NASDAQ:HCAT) and Hello Group (NASDAQ:MOMO) are both small-cap computer software companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

In the previous week, Health Catalyst had 6 more articles in the media than Hello Group. MarketBeat recorded 8 mentions for Health Catalyst and 2 mentions for Hello Group. Health Catalyst's average media sentiment score of 0.49 beat Hello Group's score of 0.30 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	1 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hello Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Hello Group has a net margin of 7.27% compared to Health Catalyst's net margin of -87.69%. Hello Group's return on equity of 7.04% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-87.69%	-3.52%	-1.77%
Hello Group	7.27%	7.04%	5.39%

Health Catalyst has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market. Comparatively, Hello Group has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market.

Health Catalyst currently has a consensus target price of $2.93, indicating a potential upside of 43.72%. Hello Group has a consensus target price of $9.05, indicating a potential upside of 52.61%. Given Hello Group's higher probable upside, analysts plainly believe Hello Group is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23
Hello Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 51.0% of Hello Group shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Comparatively, 61.4% of Hello Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Hello Group has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Hello Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.48	-$177.97M	-$3.72	N/A
Hello Group	$10.23B	0.06	$114.97M	$0.64	9.27

Summary

Hello Group beats Health Catalyst on 9 of the 16 factors compared between the two stocks.

How does Health Catalyst compare to PubMatic?

PubMatic (NASDAQ:PUBM) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

PubMatic has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market.

PubMatic has higher earnings, but lower revenue than Health Catalyst. PubMatic is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PubMatic	$282.93M	2.08	-$14.46M	-$0.38	N/A
Health Catalyst	$311.14M	0.48	-$177.97M	-$3.72	N/A

64.3% of PubMatic shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 27.8% of PubMatic shares are owned by insiders. Comparatively, 19.4% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Health Catalyst had 2 more articles in the media than PubMatic. MarketBeat recorded 8 mentions for Health Catalyst and 6 mentions for PubMatic. PubMatic's average media sentiment score of 0.54 beat Health Catalyst's score of 0.49 indicating that PubMatic is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PubMatic	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Health Catalyst	1 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PubMatic has a net margin of -6.21% compared to Health Catalyst's net margin of -87.69%. Health Catalyst's return on equity of -3.52% beat PubMatic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PubMatic	-6.21%	-6.98%	-2.60%
Health Catalyst	-87.69%	-3.52%	-1.77%

PubMatic currently has a consensus price target of $12.88, indicating a potential upside of 1.78%. Health Catalyst has a consensus price target of $2.93, indicating a potential upside of 43.72%. Given Health Catalyst's higher possible upside, analysts clearly believe Health Catalyst is more favorable than PubMatic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PubMatic	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.78
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23

Summary

PubMatic beats Health Catalyst on 9 of the 17 factors compared between the two stocks.

How does Health Catalyst compare to Similarweb?

Health Catalyst (NASDAQ:HCAT) and Similarweb (NYSE:SMWB) are both small-cap computer software companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

In the previous week, Health Catalyst had 7 more articles in the media than Similarweb. MarketBeat recorded 8 mentions for Health Catalyst and 1 mentions for Similarweb. Similarweb's average media sentiment score of 0.67 beat Health Catalyst's score of 0.49 indicating that Similarweb is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	1 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Similarweb	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Health Catalyst has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market. Comparatively, Similarweb has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market.

Health Catalyst currently has a consensus target price of $2.93, indicating a potential upside of 43.72%. Similarweb has a consensus target price of $8.07, indicating a potential upside of 27.89%. Given Health Catalyst's stronger consensus rating and higher probable upside, equities research analysts plainly believe Health Catalyst is more favorable than Similarweb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23
Similarweb	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

Similarweb has a net margin of -10.38% compared to Health Catalyst's net margin of -87.69%. Health Catalyst's return on equity of -3.52% beat Similarweb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-87.69%	-3.52%	-1.77%
Similarweb	-10.38%	-48.57%	-4.45%

Similarweb has lower revenue, but higher earnings than Health Catalyst. Similarweb is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.48	-$177.97M	-$3.72	N/A
Similarweb	$282.60M	1.96	-$32.94M	-$0.35	N/A

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 57.6% of Similarweb shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Comparatively, 62.4% of Similarweb shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Health Catalyst beats Similarweb on 10 of the 16 factors compared between the two stocks.

How does Health Catalyst compare to Weave Communications?

Health Catalyst (NASDAQ:HCAT) and Weave Communications (NYSE:WEAV) are both small-cap computer software companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

Health Catalyst has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market. Comparatively, Weave Communications has a beta of 1.68, indicating that its share price is 68% more volatile than the broader market.

In the previous week, Health Catalyst had 5 more articles in the media than Weave Communications. MarketBeat recorded 8 mentions for Health Catalyst and 3 mentions for Weave Communications. Health Catalyst's average media sentiment score of 0.49 beat Weave Communications' score of 0.46 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	1 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Weave Communications	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Weave Communications has a net margin of -10.05% compared to Health Catalyst's net margin of -87.69%. Health Catalyst's return on equity of -3.52% beat Weave Communications' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-87.69%	-3.52%	-1.77%
Weave Communications	-10.05%	-26.46%	-10.39%

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 86.8% of Weave Communications shares are owned by institutional investors. 19.4% of Health Catalyst shares are owned by company insiders. Comparatively, 16.4% of Weave Communications shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Weave Communications has lower revenue, but higher earnings than Health Catalyst. Weave Communications is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.48	-$177.97M	-$3.72	N/A
Weave Communications	$239.02M	2.05	-$28.05M	-$0.31	N/A

Health Catalyst presently has a consensus target price of $2.93, suggesting a potential upside of 43.72%. Weave Communications has a consensus target price of $10.00, suggesting a potential upside of 62.47%. Given Weave Communications' stronger consensus rating and higher probable upside, analysts plainly believe Weave Communications is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23
Weave Communications	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Health Catalyst and Weave Communications tied by winning 8 of the 16 factors compared between the two stocks.

Get Health Catalyst News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HCAT vs. The Competition

Export

Metric	Health Catalyst	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$155.18M	$1.77B	$7.01B	$12.68B
Dividend Yield	N/A	N/A	2.67%	9.42%
P/E Ratio	-0.55	74.21	26.82	23.95
Price / Sales	0.48	25.21	576.32	115.11
Price / Cash	0.99	26.89	50.60	60.45
Price / Book	0.59	5.19	10.52	6.16
Net Income	-$177.97M	-$54.76M	$3.60B	$331.73M
7 Day Performance	-10.53%	-0.11%	-1.34%	-0.92%
1 Month Performance	15.91%	5.55%	-0.29%	-2.23%
1 Year Performance	-49.63%	-10.08%	18.96%	14.79%

Health Catalyst Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HCAT Health Catalyst	3.9092 of 5 stars	$2.04 -2.9%	$2.93 +43.7%	-48.2%	$155.18M	$311.14M	N/A	1,200	Analyst Forecast Gap Up
CGNT Cognyte Software	3.4788 of 5 stars	$9.24 +2.2%	$13.50 +46.1%	-8.3%	$675.24M	$409.99M	N/A	1,710	Gap Up
MOMO Hello Group	3.6003 of 5 stars	$6.05 -1.2%	$9.05 +49.7%	-32.8%	$651.34M	$1.48B	9.46	1,400	Positive News
PUBM PubMatic	1.3468 of 5 stars	$13.80 +1.7%	$12.88 -6.7%	+1.4%	$640.83M	$282.93M	N/A	1,030	News Coverage
SMWB Similarweb	3.4377 of 5 stars	$7.19 +0.8%	$8.07 +12.3%	-29.8%	$632.47M	$282.60M	N/A	1,085

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HCAT) was last updated on 7/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health Catalyst (HCAT) Competitors

HCAT vs. CGNT, MOMO, PUBM, SMWB, and WEAV

How does Health Catalyst compare to Cognyte Software?

Summary

How does Health Catalyst compare to Hello Group?

Summary

How does Health Catalyst compare to PubMatic?

Summary

How does Health Catalyst compare to Similarweb?

Summary

How does Health Catalyst compare to Weave Communications?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCAT vs. The Competition

Health Catalyst Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health Catalyst (HCAT) Competitors

HCAT vs. CGNT, MOMO, PUBM, SMWB, and WEAV

How does Health Catalyst compare to Cognyte Software?

Which has stronger earnings & valuation, HCAT or CGNT?

Do analysts prefer HCAT or CGNT?

Is HCAT or CGNT more profitable?

Which has more volatility & risk, HCAT or CGNT?

Do institutionals & insiders believe in HCAT or CGNT?

Does the media favor HCAT or CGNT?

Summary

How does Health Catalyst compare to Hello Group?

Does the media favor HCAT or MOMO?

Is HCAT or MOMO more profitable?

Which has more volatility and risk, HCAT or MOMO?

Do analysts rate HCAT or MOMO?

Do institutionals and insiders believe in HCAT or MOMO?

Which has higher earnings and valuation, HCAT or MOMO?

Summary

How does Health Catalyst compare to PubMatic?

Which has more risk and volatility, PUBM or HCAT?

Which has higher earnings & valuation, PUBM or HCAT?

Do institutionals & insiders believe in PUBM or HCAT?

Does the media prefer PUBM or HCAT?

Is PUBM or HCAT more profitable?

Do analysts recommend PUBM or HCAT?

Summary

How does Health Catalyst compare to Similarweb?

Does the media favor HCAT or SMWB?

Which has more risk and volatility, HCAT or SMWB?

Do analysts rate HCAT or SMWB?

Is HCAT or SMWB more profitable?

Which has stronger earnings & valuation, HCAT or SMWB?

Do insiders & institutionals believe in HCAT or SMWB?

Summary

How does Health Catalyst compare to Weave Communications?

Which has more risk & volatility, HCAT or WEAV?

Does the media refer more to HCAT or WEAV?

Is HCAT or WEAV more profitable?

Do insiders and institutionals hold more shares of HCAT or WEAV?

Which has better earnings & valuation, HCAT or WEAV?

Do analysts rate HCAT or WEAV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCAT vs. The Competition

Health Catalyst Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools